Drug intelligence / Profile preview

DSP-1083

Development stage
Unknown
Lead developer
Sumitomo Pharma
Modality
Cell Therapies
Administration
Intracranial (stereotactic Implantation)
01

Overview

**DSP-1083** is an investigational cell therapy for Parkinson’s disease composed of human induced pluripotent stem cell (iPSC)-derived dopaminergic progenitor cells. The primary mechanism is to restore dopaminergic neuronal function by implantation of dopamine neural progenitors, which secrete dopamine, aiming to ameliorate neurological symptoms of Parkinson’s disease. The therapy is currently under clinical development, with safety, tolerability, and efficacy being assessed in a first-in-human, multicenter trial. The sponsor and primary developer is Sumitomo Pharma America. Clinical administration involves stereotactic implantation into the brain[1][2][4][5][6].

Brand names
DSP-1083DSP1083DSP 1083
Other names
iPSC-derived dopaminergic progenitorsiPS cell-derived DA progenitorsinduced pluripotent stem cell-derived dopaminergic progenitors

Beyond the preview

Go deeper on DSP-1083.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSP-1083.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call